annual cash & cash equivalents:
$435.45M+$313.82M(+258.02%)Summary
- As of today (August 20, 2025), DYN annual cash & cash equivalents is $435.45 million, with the most recent change of +$313.82 million (+258.02%) on December 31, 2024.
- During the last 3 years, DYN annual cash & cash equivalents has risen by +$234.62 million (+116.83%).
- DYN annual cash & cash equivalents is now at all-time high.
Performance
DYN Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$683.92M+$6.43M(+0.95%)Summary
- As of today (August 20, 2025), DYN quarterly cash & cash equivalents is $683.92 million, with the most recent change of +$6.43 million (+0.95%) on June 30, 2025.
- Over the past year, DYN quarterly cash & cash equivalents has dropped by -$94.91 million (-12.19%).
- DYN quarterly cash & cash equivalents is now -12.19% below its all-time high of $778.84 million, reached on June 30, 2024.
Performance
DYN quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DYN Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +258.0% | -12.2% |
| 3 y3 years | +116.8% | +134.3% |
| 5 y5 years | +2876.0% | +372.1% |
DYN Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +258.0% | -12.2% | +455.6% |
| 5 y | 5-year | at high | +2876.0% | -12.2% | +455.6% |
| alltime | all time | at high | +5260.0% | -12.2% | +4574.2% |
DYN Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $683.92M(+0.9%) |
| Mar 2025 | - | $677.49M(+5.5%) |
| Dec 2024 | $435.45M(+258.0%) | $642.27M(-11.2%) |
| Sep 2024 | - | $723.67M(-7.1%) |
| Jun 2024 | - | $778.84M(+71.7%) |
| Mar 2024 | - | $453.55M(+268.4%) |
| Dec 2023 | $121.63M(-29.3%) | $123.10M(-22.0%) |
| Sep 2023 | - | $157.82M(-24.0%) |
| Jun 2023 | - | $207.73M(-12.8%) |
| Mar 2023 | - | $238.21M(-7.0%) |
| Dec 2022 | $172.15M | $256.01M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $248.14M(-15.0%) |
| Jun 2022 | - | $291.84M(-9.7%) |
| Mar 2022 | - | $323.15M(-14.2%) |
| Dec 2021 | $200.82M(-33.2%) | $376.57M(-7.6%) |
| Sep 2021 | - | $407.52M(-6.4%) |
| Jun 2021 | - | $435.59M(-9.8%) |
| Mar 2021 | - | $483.08M(+39.9%) |
| Dec 2020 | $300.85M(+1956.1%) | $345.31M(-9.0%) |
| Sep 2020 | - | $379.61M(+162.0%) |
| Jun 2020 | - | $144.87M(+890.1%) |
| Dec 2019 | $14.63M(+80.1%) | $14.63M |
| Dec 2018 | $8.12M | - |
FAQ
- What is Dyne Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Dyne Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of DYN is $435.45M
What is the all time high annual cash & cash equivalents for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high annual cash & cash equivalents is $435.45M
What is Dyne Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, DYN annual cash & cash equivalents has changed by +$313.82M (+258.02%)
What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DYN is $683.92M
What is the all time high quarterly cash & cash equivalents for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $778.84M
What is Dyne Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, DYN quarterly cash & cash equivalents has changed by -$94.91M (-12.19%)